至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

A CRISPR-Cas9 Assisted Non-Homologous End-Joining Strategy for One-step Engineering of Bacterial Genome.

Sci Rep. 2016; 
Su Tianyuan,Liu Fapeng,Gu Pengfei,Jin Haiying,Chang Yizhao,Wang Qian,Liang Quanfeng,Qi Qings
Products/Services Used Details Operation
CRISPR Bacteria & Yeast Engineering To obtain the sgRNA expression plasmid p15A-gRNA, the BsaI-sgRNA module containing two BsaI type IIS sites, allowing the insertion of new spacers, was synthesized by Genscript.... To construct p15A-BsaI-BbsI-sgRNA, the BbsI-sgRNA-terminator module containing two BbsI type IIS sites was synthesized by Genscript. Get A Quote

摘要

Homologous recombination-mediated genome engineering has been broadly applied in prokaryotes with high efficiency and accuracy. However, this method is limited in realizing larger-scale genome editing with numerous genes or large DNA fragments because of the relatively complicated procedure for DNA editing template construction. Here, we describe a CRISPR-Cas9 assisted non-homologous end-joining (CA-NHEJ) strategy for the rapid and efficient inactivation of bacterial gene (s) in a homologous recombination-independent manner and without the use of selective marker. Our study show that CA-NHEJ can be used to delete large chromosomal DNA fragments in a single step that does not require homologous DNA template.... More

关键词